Home » Accessing Aquablation® Therapy in the UK

Accessing Aquablation® Therapy in the UK

PROCEPT® BioRobotics is committed to supporting healthcare professionals and patients in navigating the insurance process. The site contains information and resources that you may need throughout the process.

NHS

Aquablation therapy is a NICE recommended procedure and is available on the NHS.

Any NHS hospital that offers Aquablation therapy can provide this robotic-assisted BPH treatment to patients within England and the United Kingdom.

If your local NHS hospital does not offer Aquablation therapy you can ask your GP or urologist to refer to you to an NHS urologist or hospital that does.

Private Insurance

Aquablation therapy is covered by ALL major private insurance companies and is available at all private hospitals who offer Aquablation therapy in the United Kingdom.

You will need to obtain pre-authorisation prior to the procedure and you may be required to submit further documentation or clinical support from your urologist to gain authorisation.

Self-Pay

All NHS and private hospitals who offer Aquablation therapy in the United Kingdom will offer a self-pay option for Aquablation therapy.

Costs vary and we recommend you contact the provider for a price estimate.

NICE approval

Patients can be assured that Aquablation therapy has undergone rigorous evaluation and has met the standards set by NICE in terms of clinical effectiveness and value for money.

Aquablation therapy has been awarded the National Institute for Clinical Excellence’s (NICE) most positive recommendation ‘Standard Arrangement’

A NICE ‘standard arrangement’ is a first-class endorsement of the procedure and it means that they have recognised that there is sufficient evidence for doctors to safely consider Aquablation therapy as an option for all patients requiring treatment for symptoms resulting from an enlarged prostate.

NICE plays a pivotal role in providing guidance to enhance health and social care in the United Kingdom. For a procedure to secure such a recommendation, it must demonstrate both short-term and long-term safety and efficacy. NICE’s endorsement underscores that the robotically assisted Aquablation therapy meets these rigorous standards.